NYSE$PHR

Phreesia Inc · Q1 2023 earnings

Q1 2023 earnings · · Investor relations

Briefing

Announced fiscal first quarter 2023 results, showing revenue growth and client expansion.

Phreesia reported a strong start to fiscal year 2023, with a 31% increase in revenue compared to the same period last year. The company saw gains in new clients and expansion within existing clients across healthcare services and life sciences. The company is maintaining its revenue outlook for fiscal 2023 of $271 million to $275 million implying year-over-year growth of 27% to 29%.

  • Revenue increased by 31% to $63.4 million compared to $48.3 million in the same period last year.
  • Average number of healthcare services clients increased by 33% to 2,526 compared to 1,902 in the same period last year.
  • Adjusted EBITDA was negative $30.6 million compared to positive $0.1 million in the same period last year.
  • Cash and cash equivalents totaled $269.2 million as of April 30, 2022.

Headline financials

Total Revenue

$63.4M

Previous: $48.3M+31.2%
EPS (adj)

-$0.99

Previous: -$0.11-800.0%
Avg. Healthcare Clients

2.5K

Previous: 1.9K+32.8%
Patient Payment Volume

$837M

No prior period
Payment Facilitator % Volume

80.0%

Previous: 78.0%+2.6%
Capital Expenditures

-$1.79M

Previous: -$3.98M+55.2%
Free Cash Flow

-$53M

Previous: -$15M-254.5%
Net Income

-$51.2M

Previous: -$11M-366.9%
Operating Income

-$50.6M

Previous: -$10.7M-374.9%
Gross Profit

$49M

Previous: $39.8M+23.2%
Cash & Equivalents

$269M

Previous: $451M-40.3%
Total Assets

$459M

Previous: $561M-18.2%
Stock-Based Comp

$14.2M

Previous: $5.77M+145.1%

Revenue & EPS history

Phreesia · Revenue · Quarterly

$63.4M

Q1 2023+31.2%vs Q1 2022
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Phreesia · $48.5M total across 2 segments · Q1 2023

  • Subscription Services
    $29.1M+33.4%
  • Payment Processing
    $19.4M+16.4%

Forward guidance

Phreesia is maintaining its revenue outlook for fiscal year 2023 of $271 million to $275 million implying year-over-year growth of 27% to 29%. They are raising their Adjusted EBITDA outlook for fiscal year 2023 to negative $126 million to negative $122 million from a previous range of negative $154 million to negative $149 million.

Tailwinds

  • Revenue outlook for fiscal year 2023 maintained at $271 million to $275 million, implying 27% to 29% year-over-year growth.
  • Adjusted EBITDA outlook for fiscal year 2023 raised to negative $126 million to negative $122 million.
  • Expectation that Adjusted EBITDA outlook in fiscal year 2023 will be the low annual mark for fiscal years 2023 to 2025 maintained.
  • Company expects to reach profitability in fiscal year 2025.
  • Annualized revenue target of $500 million to be achieved during a quarter of fiscal year 2025 is maintained.

Headwinds

  • Adjusted EBITDA was negative $30.6 million in the quarter.
  • Cash and cash equivalents decreased by $44.6 million compared to January 31, 2022.
  • Adjusted EBITDA outlook has not been reconciled to GAAP Net income (loss).
  • Uncertainty and potential variability of Other (income) expense, net and (Benefit from) provision for income taxes.
  • Reconciliation of the non-GAAP financial measure outlook to the corresponding GAAP measure is not available without unreasonable effort.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q1 2023

Historical avgQ1 2023

-1.6%

Avg return

Earnings day

+2.5%

Avg return

5 days after

+2.0%

Avg return

30 days after

54%

15 / 28 earnings

Positive

+21.4%

Q2 2023

Best reaction

-26.3%

Q4 2026

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-26.3%-1.1%
Q1 2027+2.3%+13.3%
Q3 2026-22.8%-19.2%-16.0%
Q2 2026-9.8%-18.8%-25.4%
Q1 2026-6.6%-0.2%+14.2%
Q4 2025+6.9%+14.6%+1.1%
Q3 2025+11.1%+14.8%+30.8%
Q2 2025+7.9%+0.5%-6.8%
Q1 2025-13.3%-14.7%-2.9%
Q4 2024+1.7%-0.7%+1.0%
Q3 2024+17.8%+18.8%+45.2%
Q2 2024-21.2%-27.1%-39.1%
Q1 2024+3.6%+10.3%+4.0%
Q4 2023-13.5%-10.0%-5.7%
Q3 2023+18.7%+34.8%+20.0%
Q2 2023+21.4%+28.2%+4.9%
Q1 2023+11.9%+17.5%+40.1%
Q4 2022-11.9%+1.3%-23.6%
Q3 2022-20.2%-20.9%-32.9%
Q2 2022-12.4%-6.2%-15.4%
Q1 2022+6.6%+12.7%+24.2%
Q4 2021+2.5%+8.4%+3.3%
Q3 2021+7.3%+18.1%+16.2%
Q2 2021-3.2%-9.2%+3.5%
Q1 2021-6.7%-10.5%-13.1%
Q4 2020+4.2%+18.1%+30.6%
Q3 2020-1.0%-8.8%-6.9%
Q2 2020+0.2%+7.3%+1.2%
Q1 2020
Q4 2019
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro